Study of Maggot Therapy in Diabetic Foot Ulcers (MDT)

September 7, 2012 updated by: Forough Pouryazdanpanah Kermani, Kerman Medical University

Maggot Therapy in Diabetic Foot Ulcers

This study was a Kind of clinical trial with equal randomization, that have been done from January 2009 to June 2011 in the AFZALIPOOR hospital endocrine ward in Kerman-Iran on 128 diabetic patient who had foot wounds.Replacement of conventional therapy by new methodes is one of the more important aims for health professional specially for nurses.One of this new treatment is maggot therapy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

128

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have a chronic illness more than 7 weeks.
  • The age of the patients between 40- 90 years old.
  • Not having capillary disease (Blockage of artery, Rinold).
  • Not user of anticoagulants and corticosteroids drugs.
  • Patients without history of allergy to drugs and foods.
  • Having diabetic type 2

Exclusion Criteria:

  • patients who refer to critical clinical care unit
  • patients who have amputation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MAGGOT THERAPY & conventional therapy T
Maggot therapy,ADMINISTERED TWO TIMES AS A NEW METHODS OF DRESSING in experimental group.conventional therapy ,administered two times in control group
each times in maggot therapy continued for three days.wound assessment was done before and after any intervention
Other Names:
  • larval therapy
patients receive ordinary treatment for diabetic foot
Other Names:
  • mechanical debridement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 3days and change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 6 days
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2009

Primary Completion (Actual)

December 1, 2009

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

September 4, 2012

First Submitted That Met QC Criteria

September 6, 2012

First Posted (Estimate)

September 7, 2012

Study Record Updates

Last Update Posted (Estimate)

September 10, 2012

Last Update Submitted That Met QC Criteria

September 7, 2012

Last Verified

September 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on DIABETIC FOOT ULCERS

Clinical Trials on procedure:maggot therapy

3
Subscribe